NCT06520098 2025-10-14
Benefit VA
VA Office of Research and Development
Phase 2 Recruiting
Clinical Trials
4 trialsNCT00028418 2015-03-25
Clofarabine in Chronic Lymphocytic Leukemia
FDA Office of Orphan Products Development
Phase 1 Completed
NCT00100477 2013-09-25
Use of Topotecan in Patients With Refractory Acute Leukemia
VA Office of Research and Development
Phase 2 Completed
NCT00728520 2008-08-06
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Kansas City Veteran Affairs Medical Center
Phase 2 Unknown